Skip to main content
HairCited

Микронидлинг для Андрогенетическая алопеция

A

На основе 52 исследований (5 meta-analyses, 11 RCTs) с участием 8,451 участников. 44/52 исследований показывают положительные эффекты.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dmicroneedling\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Итог

Microneedling has strong, well-established evidence for androgenetic alopecia, particularly when combined with topical minoxidil, and is one of the best-supported adjunct therapies for pattern hair loss.

  • 44 out of 52 studies show positive effects, supported by 5 meta-analyses and 11 RCTs
  • Most effective when combined with topical minoxidil, significantly boosting its effectiveness
  • Stimulates growth factors and wound-healing pathways that support hair follicle regeneration
  • Both professional and at-home microneedling approaches have demonstrated benefits

Key Study Findings

non-randomized controlled trial n=60 16 weeks Open-label
Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of …
Dose: Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); или: Placebo Эффект: All groups showed significant decrease in HLSS and increase in hair density post-treatment (p<0.001) p<0.001
Controlled Clinical Trial n=8 12 weeks Single-blind
Dutasteride Infusion in Male Androgenetic Alopecia Using a Novel Drug Delivery Technique: MMP®.
Dose: 3 sessions of dutasteride microinfusion (monthly) или: Saline solution placebo via MMP Outcome: Clinical assessment and patient self-assessment Эффект: None None

Популяция: Adult males with androgenetic alopecia

Review
Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia.
Dose: None или: None Outcome: None Эффект: None None

Популяция: None

review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera или: Placebo Эффект: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) или: Placebo Эффект: None None

Key Statistics

62

Исследования

8574

Участники

Positive

A

Оценка

Referenced Papers

Aesthetic plastic surgery 2025 14 цитирований
Cureus 2025 7 цитирований
Journal of cutaneous … 2025 2 цитирований
Dermatology (Basel, Switzerland) 2024 14 цитирований
Journal of cosmetic … 2024 11 цитирований
Journal of clinical … 2024 10 цитирований
Lasers in medical … 2024 10 цитирований
Journal of cosmetic … 2024 8 цитирований
Journal of cutaneous … 2024 3 цитирований
Clinical, cosmetic and … 2023 58 цитирований
Skin appendage disorders 2023 4 цитирований
Dermatologic surgery : … 2023 2 цитирований
Asian journal of … 2023 2 цитирований
Faculty reviews 2022 44 цитирований
Dermatology and therapy 2022 43 цитирований
Journal of cosmetic … 2022 35 цитирований
Dermatologic surgery : … 2022 15 цитирований
Journal of cosmetic … 2022 9 цитирований
Dermatologic surgery : … 2021 58 цитирований
Journal of cosmetic … 2021 39 цитирований
Dermatologic therapy 2020 48 цитирований
Journal of cosmetic … 2020 45 цитирований
Journal of the … 2019 13 цитирований
Dermatology and therapy 2019 7 цитирований
Journal of plastic, … 2018 137 цитирований
Journal of the … 2018 114 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

hairloss:
1.5 mm depth, weekly sessions

Верхний предел: Not applicable

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); 16 weeks Positive 60
3 sessions of dutasteride microinfusion (monthly) 12 weeks Positive 8
None -- Mixed --
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
None -- Mixed --
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
None -- Positive 631
None -- Mixed --

Лучшее время приёма: Weekly sessions; avoid minoxidil for 24 hours post-treatment

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Scalp redness and inflammation (24-72 hours)
  • Mild bleeding at treatment site
  • Scalp tenderness and soreness
  • Rare: infection if proper sterilization not maintained

Известные взаимодействия

  • Topical minoxidil (enhanced absorption; wait 24 hours after microneedling to apply)
  • Blood thinners (may increase bleeding during procedure)
  • Topical retinoids (discontinue 3-5 days before treatment)

Допустимый верхний уровень потребления: Not applicable

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Микронидлинг help with Андрогенетическая алопеция?
Based on 62 studies with 8,574 participants, there is strong evidence from multiple clinical trials that Микронидлинг may support Андрогенетическая алопеция management. Our evidence grade is A (Strong Evidence).
How much Микронидлинг should I take for Андрогенетическая алопеция?
Studies have used various dosages. A commonly studied range is 1.5 mm depth, weekly sessions. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Микронидлинг?
Reported side effects may include Scalp redness and inflammation (24-72 hours), Mild bleeding at treatment site, Scalp tenderness and soreness, Rare: infection if proper sterilization not maintained. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Микронидлинг and Андрогенетическая алопеция?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 62 peer-reviewed studies with 8,574 total participants. The overall direction of effect is positive.

Related Evidence

Микронидлинг для других состояний

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.